References: Long-term rhythm control for atrial fibrillation

  • Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42(5):373-498. https://www.ncbi.nlm.nih.gov/pubmed/32860505
  • Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 2019;321(13):1275-85. https://www.ncbi.nlm.nih.gov/pubmed/30874716
  • NHFA CSANZ Atrial fibrillation guideline working group, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ 2018;27(10):1209-66. https://www.ncbi.nlm.nih.gov/pubmed/30077228
  • Piccini JP, Fauchier L. Rhythm control in atrial fibrillation. Lancet 2016;388(10046):829-40. https://www.ncbi.nlm.nih.gov/pubmed/27560278
  • Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996;348(9019):7-12. https://www.ncbi.nlm.nih.gov/pubmed/8691967